Microbial determinants of biochemical individuality and their impact on toxicology and pharmacology

Cell Metabolism

Volumn 20, Issue 5, 2014, Pages 761-768

  Patterson, Andrew D ^a   Turnbaugh, Peter J ^b  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIDIABETIC AGENT; ANTIOXIDANT; CARCINOGEN; CARDIAC GLYCOSIDE; DIGOXIN; FARNESOID X RECEPTOR; FATTY ACID; HIPPURIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; OLANZAPINE; PARA CRESOL; PHENYLACETYLGLUTAMINE; RNA 16S; SIMVASTATIN; TEMPOL; TOXIN; UNCLASSIFIED DRUG; XENOBIOTIC AGENT; DRUG;

ACTINOBACTERIA; BACTEROIDETES; BIOCHEMICAL INDIVIDUALITY; BIOTRANSFORMATION; CAENORHABDITIS ELEGANS; CARDIOVASCULAR DISEASE; CLOSTRIDIUM; COMMUNITY STRUCTURE; DIABETES MELLITUS; DRUG EFFICACY; DRUG METABOLISM; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVITY; ESCHERICHIA COLI; EUBACTERIUM; FECES ANALYSIS; GENE SEQUENCE; GENETIC VARIABILITY; HOST PATHOGEN INTERACTION; HUMAN; HYPERCHOLESTEROLEMIA; INDIVIDUALITY; LACTOBACILLUS; METABOLITE; METABOLOMICS; METAGENOMICS; MICROBIAL COMMUNITY; MICROBIOME; MICROORGANISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; QUANTITATIVE ANALYSIS; REVIEW; WEIGHT GAIN; XENOBIOTIC METABOLISM; ANIMAL; GASTROINTESTINAL TRACT; METABOLISM; MICROBIOLOGY; MICROFLORA; PHARMACOLOGY; TOXICOLOGY;

ANIMALS; GASTROINTESTINAL TRACT; HUMANS; MICROBIOTA; PHARMACEUTICAL PREPARATIONS; PHARMACOLOGY; TOXICOLOGY; XENOBIOTICS;

EID: 84910122098     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2014.07.002     Document Type: Review

References (87)

1. F. Bäckhed, H. Ding, T. Wang, L.V. Hooper, G.Y. Koh, A. Nagy, C.F. Semenkovich, and J.I. Gordon The gut microbiota as an environmental factor that regulates fat storage Proc. Natl. Acad. Sci. USA 101 2004 15718 15723
2. B. Björkholm, C.M. Bok, A. Lundin, J. Rafter, M.L. Hibberd, and S. Pettersson Intestinal microbiota regulate xenobiotic metabolism in the liver PLoS ONE 4 2009 e6958
3. F. Cabreiro, C. Au, K.Y. Leung, N. Vergara-Irigaray, H.M. Cochemé, T. Noori, D. Weinkove, E. Schuster, N.D. Greene, and D. Gems Metformin retards aging in C. Elegans by altering microbial folate and methionine metabolism Cell 153 2013 228 239
4. J.G. Caporaso, J. Kuczynski, J. Stombaugh, K. Bittinger, F.D. Bushman, E.K. Costello, N. Fierer, A.G. Peña, J.K. Goodrich, and J.I. Gordon QIIME allows analysis of high-throughput community sequencing data Nat. Methods 7 2010 335 336
5. J.G. Caporaso, C.L. Lauber, E.K. Costello, D. Berg-Lyons, A. Gonzalez, J. Stombaugh, D. Knights, P. Gajer, J. Ravel, and N. Fierer Moving pictures of the human microbiome Genome Biol. 12 2011 R50
6. R.N. Carmody, and P.J. Turnbaugh Host-microbial interactions in the metabolism of therapeutic and diet-derived xenobiotics J. Clin. Invest. 2014 in press
7. M.J. Claesson, I.B. Jeffery, S. Conde, S.E. Power, E.M. O'Connor, S. Cusack, H.M. Harris, M. Coakley, B. Lakshminarayanan, and O. O'Sullivan Gut microbiota composition correlates with diet and health in the elderly Nature 488 2012 178 184
8. T.A. Clayton, D. Baker, J.C. Lindon, J.R. Everett, and J.K. Nicholson Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism Proc. Natl. Acad. Sci. USA 106 2009 14728 14733
9. T.H.M.P. Consortium Human Microbiome Project Consortium Structure, function and diversity of the healthy human microbiome Nature 486 2012 207 214
10. K.J. Davey, P.D. Cotter, O. O'Sullivan, F. Crispie, T.G. Dinan, J.F. Cryan, and S.M. O'Mahony Antipsychotics and the gut microbiome: olanzapine-induced metabolic dysfunction is attenuated by antibiotic administration in the rat Transcult. Psychiatry 3 2013 e309
11. L.A. David, C.F. Maurice, R.N. Carmody, D.B. Gootenberg, J.E. Button, B.E. Wolfe, A.V. Ling, A.S. Devlin, Y. Varma, and M.A. Fischbach Diet rapidly and reproducibly alters the human gut microbiome Nature 505 2014 559 563
12. E.F. DeLong, G.S. Wickham, and N.R. Pace Phylogenetic stains: ribosomal RNA-based probes for the identification of single cells Science 243 1989 1360 1363
13. L. Dethlefsen, and D.A. Relman Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation Proc. Natl. Acad. Sci. USA 108 Suppl 1 2011 4554 4561
14. T. Ding, and P.D. Schloss Dynamics and associations of microbial community types across the human body Nature 509 2014 357 360
15. M.G. Dominguez-Bello, E.K. Costello, M. Contreras, M. Magris, G. Hidalgo, N. Fierer, and R. Knight Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns Proc. Natl. Acad. Sci. USA 107 2010 11971 11975
16. A. Everard, C. Belzer, L. Geurts, J.P. Ouwerkerk, C. Druart, L.B. Bindels, Y. Guiot, M. Derrien, G.G. Muccioli, and N.M. Delzenne Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity Proc. Natl. Acad. Sci. USA 110 2013 9066 9071
17. J.J. Faith, J.L. Guruge, M. Charbonneau, S. Subramanian, H. Seedorf, A.L. Goodman, J.C. Clemente, R. Knight, A.C. Heath, and R.L. Leibel The long-term stability of the human gut microbiota Science 341 2013 1237439
18. J. Feng, C.E. Cerniglia, and H. Chen Toxicological significance of azo dye metabolism by human intestinal microbiota Front Biosci (Elite Ed) 4 2012 568 586
19. R. Flores, J. Shi, B. Fuhrman, X. Xu, T.D. Veenstra, M.H. Gail, P. Gajer, J. Ravel, and J.J. Goedert Fecal microbial determinants of fecal and systemic estrogens and estrogen metabolites: a cross-sectional study J. Transl. Med. 10 2012 253
20. G.E. Fox, E. Stackebrandt, R.B. Hespell, J. Gibson, J. Maniloff, T.A. Dyer, R.S. Wolfe, W.E. Balch, R.S. Tanner, and L.J. Magrum The phylogeny of prokaryotes Science 209 1980 457 463
21. P. Frank, M.A. Ottoboni, and M.A. Ottoboni The Dose Makes the Poison: A Plain-Language Guide to Toxicology 2011 Wiley Hoboken, N.J.
22. P. Gajer, R.M. Brotman, G. Bai, J. Sakamoto, U.M. Schutte, X. Zhong, S.S. Koenig, L. Fu, Z.S. Ma, and X. Zhou Temporal dynamics of the human vaginal microbiota Sci. Transl. Med. 4 2012 132ra152
23. S. Greenblum, P.J. Turnbaugh, and E. Borenstein Metagenomic systems biology of the human gut microbiome reveals topological shifts associated with obesity and inflammatory bowel disease Proc. Natl. Acad. Sci. USA 109 2012 594 599
24. H.J. Haiser, and P.J. Turnbaugh Is it time for a metagenomic basis of therapeutics? Science 336 2012 1253 1255
25. H.J. Haiser, and P.J. Turnbaugh Developing a metagenomic view of xenobiotic metabolism Pharmacol. Res. 69 2013 21 31
26. H.J. Haiser, D.B. Gootenberg, K. Chatman, G. Sirasani, E.P. Balskus, and P.J. Turnbaugh Predicting and manipulating cardiac drug inactivation by the human gut bacterium Eggerthella lenta Science 341 2013 295 298
27. H.J. Haiser, K.L. Seim, E.P. Balskus, and P.J. Turnbaugh Mechanistic insight into digoxin inactivation by Eggerthella lenta augments our understanding of its pharmacokinetics Gut Microbes 5 2014 233 238
28. J.H. Hehemann, G. Correc, T. Barbeyron, W. Helbert, M. Czjzek, and G. Michel Transfer of carbohydrate-active enzymes from marine bacteria to Japanese gut microbiota Nature 464 2010 908 912
29. J.H. Hehemann, A.G. Kelly, N.A. Pudlo, E.C. Martens, and A.B. Boraston Bacteria of the human gut microbiome catabolize red seaweed glycans with carbohydrate-active enzyme updates from extrinsic microbes Proc. Natl. Acad. Sci. USA 109 2012 19786 19791
30. E.Y. Hsiao, S.W. McBride, S. Hsien, G. Sharon, E.R. Hyde, T. McCue, J.A. Codelli, J. Chow, S.E. Reisman, and J.F. Petrosino Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders Cell 155 2013 1451 1463
31. S.M. Huse, Y. Ye, Y. Zhou, and A.A. Fodor A core human microbiome as viewed through 16S rRNA sequence clusters PLoS ONE 7 2012 e34242
32. N. Iida, A. Dzutsev, C.A. Stewart, L. Smith, N. Bouladoux, R.A. Weingarten, D.A. Molina, R. Salcedo, T. Back, and S. Cramer Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment Science 342 2013 967 970
33. R. Kaddurah-Daouk, R.A. Baillie, H. Zhu, Z.B. Zeng, M.M. Wiest, U.T. Nguyen, K. Wojnoonski, S.M. Watkins, M. Trupp, and R.M. Krauss Enteric microbiome metabolites correlate with response to simvastatin treatment PLoS ONE 6 2011 e25482
34. F.H. Karlsson, V. Tremaroli, I. Nookaew, G. Bergström, C.J. Behre, B. Fagerberg, J. Nielsen, and F. Bäckhed Gut metagenome in European women with normal, impaired and diabetic glucose control Nature 498 2013 99 103
35. C.D. Klaassen, L.J. Casarett, and J. Doull Casarett and Doull's Toxicology: The Basic Science of Poisons 2013 McGraw-Hill New York
36. J.E. Koenig, A. Spor, N. Scalfone, A.D. Fricker, J. Stombaugh, R. Knight, L.T. Angenent, and R.E. Ley Succession of microbial consortia in the developing infant gut microbiome Proc. Natl. Acad. Sci. USA 108 Suppl 1 2011 4578 4585
37. R.A. Koeth, Z. Wang, B.S. Levison, J.A. Buffa, E. Org, B.T. Sheehy, E.B. Britt, X. Fu, Y. Wu, and L. Li Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis Nat. Med. 19 2013 576 585
38. O. Koren, J.K. Goodrich, T.C. Cullender, A. Spor, K. Laitinen, H.K. Bäckhed, A. Gonzalez, J.J. Werner, L.T. Angenent, and R. Knight Host remodeling of the gut microbiome and metabolic changes during pregnancy Cell 150 2012 470 480
39. O. Koren, D. Knights, A. Gonzalez, L. Waldron, N. Segata, R. Knight, C. Huttenhower, and R.E. Ley A guide to enterotypes across the human body: meta-analysis of microbial community structures in human microbiome datasets PLoS Comput. Biol. 9 2013 e1002863
40. A.D. Kostic, E. Chun, L. Robertson, J.N. Glickman, C.A. Gallini, M. Michaud, T.E. Clancy, D.C. Chung, P. Lochhead, and G.L. Hold Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment Cell Host Microbe 14 2013 207 215
41. K. Kurokawa, T. Itoh, T. Kuwahara, K. Oshima, H. Toh, A. Toyoda, H. Takami, H. Morita, V.K. Sharma, and T.P. Srivastava Comparative metagenomics revealed commonly enriched gene sets in human gut microbiomes DNA Res. 14 2007 169 181
42. D.J. Lane, B. Pace, G.J. Olsen, D.A. Stahl, M.L. Sogin, and N.R. Pace Rapid determination of 16S ribosomal RNA sequences for phylogenetic analyses Proc. Natl. Acad. Sci. USA 82 1985 6955 6959
43. E. Le Chatelier, T. Nielsen, J. Qin, E. Prifti, F. Hildebrand, G. Falony, M. Almeida, M. Arumugam, J.M. Batto, S. Kennedy MetaHIT Consortium Richness of human gut microbiome correlates with metabolic markers Nature 500 2013 541 546
44. H.J. Lees, J.R. Swann, I.D. Wilson, J.K. Nicholson, and E. Holmes Hippurate: the natural history of a mammalian-microbial cometabolite J. Proteome Res. 12 2013 1527 1546
45. R.E. Ley, M. Hamady, C. Lozupone, P.J. Turnbaugh, R.R. Ramey, J.S. Bircher, M.L. Schlegel, T.A. Tucker, M.D. Schrenzel, R. Knight, and J.I. Gordon Evolution of mammals and their gut microbes Science 320 2008 1647 1651
46. F. Li, C. Jiang, K.W. Krausz, Y. Li, I. Albert, H. Hao, K.M. Fabre, J.B. Mitchell, A.D. Patterson, and F.J. Gonzalez Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity Nat. Commun. 4 2013 2384
47. A. LoGuidice, B.D. Wallace, L. Bendel, M.R. Redinbo, and U.A. Boelsterli Pharmacologic targeting of bacterial β-glucuronidase alleviates nonsteroidal anti-inflammatory drug-induced enteropathy in mice J. Pharmacol. Exp. Ther. 341 2012 447 454
48. K. Lu, R.P. Abo, K.A. Schlieper, M.E. Graffam, S. Levine, J.S. Wishnok, J.A. Swenberg, S.R. Tannenbaum, and J.G. Fox Arsenic exposure perturbs the gut microbiome and its metabolic profile in mice: an integrated metagenomics and metabolomics analysis Environ. Health Perspect. 122 2014 284 291
49. K. Lu, R. Mahbub, P.H. Cable, H. Ru, N.M. Parry, W.M. Bodnar, J.S. Wishnok, M. Styblo, J.A. Swenberg, J.G. Fox, and S.R. Tannenbaum Gut microbiome phenotypes driven by host genetics affect arsenic metabolism Chem. Res. Toxicol. 27 2014 172 174
50. Q. Ma, and A.Y. Lu Pharmacogenetics, pharmacogenomics, and individualized medicine Pharmacol. Rev. 63 2011 437 459
51. S.A. Moser, and D.C. Savage Bile salt hydrolase activity and resistance to toxicity of conjugated bile salts are unrelated properties in lactobacilli Appl. Environ. Microbiol. 67 2001 3476 3480
52. P.J. Murphy Xenobiotic metabolism: a look from the past to the future Drug Metab. Dispos. 29 2001 779 780
53. J.W. Newcomer Metabolic risk during antipsychotic treatment Clin. Ther. 26 2004 1936 1946
54. B. Olle Medicines from microbiota Nat. Biotechnol. 31 2013 309 315
55. J. Qin, Y. Li, Z. Cai, S. Li, J. Zhu, F. Zhang, S. Liang, W. Zhang, Y. Guan, and D. Shen A metagenome-wide association study of gut microbiota in type 2 diabetes Nature 490 2012 55 60
56. D.N. Reshef, Y.A. Reshef, H.K. Finucane, S.R. Grossman, G. McVean, P.J. Turnbaugh, E.S. Lander, M. Mitzenmacher, and P.C. Sabeti Detecting novel associations in large data sets Science 334 2011 1518 1524
57. V.K. Ridaura, J.J. Faith, F.E. Rey, J. Cheng, A.E. Duncan, A.L. Kau, N.W. Griffin, V. Lombard, B. Henrissat, and J.R. Bain Gut microbiota from twins discordant for obesity modulate metabolism in mice Science 341 2013 1241214
58. K.K. Ryan, V. Tremaroli, C. Clemmensen, P. Kovatcheva-Datchary, A. Myronovych, R. Karns, H.E. Wilson-Pérez, D.A. Sandoval, R. Kohli, F. Bäckhed, and R.J. Seeley FXR is a molecular target for the effects of vertical sleeve gastrectomy Nature 509 2014 183 188
59. K.S. Saitta, C. Zhang, K.K. Lee, K. Fujimoto, M.R. Redinbo, and U.A. Boelsterli Bacterial β-glucuronidase inhibition protects mice against enteropathy induced by indomethacin, ketoprofen or diclofenac: mode of action and pharmacokinetics Xenobiotica 44 2014 28 35
60. E.J. Saude, D. Adamko, B.H. Rowe, T. Marrie, and B.D. Sykes Variation of metabolites in normal human urine Metabolomics 3 2007 439 451
61. S.I. Sayin, A. Wahlström, J. Felin, S. Jäntti, H.U. Marschall, K. Bamberg, B. Angelin, T. Hyötyläinen, M. Orešič, and F. Bäckhed Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist Cell Metab. 17 2013 225 235
62. R.R. Scheline Metabolism of foreign compounds by gastrointestinal microorganisms Pharmacol. Rev. 25 1973 451 523
63. S. Schloissnig, M. Arumugam, S. Sunagawa, M. Mitreva, J. Tap, A. Zhu, A. Waller, D.R. Mende, J.R. Kultima, and J. Martin Genomic variation landscape of the human gut microbiome Nature 493 2013 45 50
64. P.D. Schloss, and J. Handelsman Biotechnological prospects from metagenomics Curr. Opin. Biotechnol. 14 2003 303 310
65. N.R. Shin, J.C. Lee, H.Y. Lee, M.S. Kim, T.W. Whon, M.S. Lee, and J.W. Bae An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice Gut 63 2014 727 735
66. C.S. Smillie, M.B. Smith, J. Friedman, O.X. Cordero, L.A. David, and E.J. Alm Ecology drives a global network of gene exchange connecting the human microbiome Nature 480 2011 241 244
67. M.I. Smith, T. Yatsunenko, M.J. Manary, I. Trehan, R. Mkakosya, J. Cheng, A.L. Kau, S.S. Rich, P. Concannon, and J.C. Mychaleckyj Gut microbiomes of Malawian twin pairs discordant for kwashiorkor Science 339 2013 548 554
68. S.M. Snedeker, and A.G. Hay Do interactions between gut ecology and environmental chemicals contribute to obesity and diabetes? Environ. Health Perspect. 120 2012 332 339
69. T. Sousa, R. Paterson, V. Moore, A. Carlsson, B. Abrahamsson, and A.W. Basit The gastrointestinal microbiota as a site for the biotransformation of drugs Int. J. Pharm. 363 2008 1 25
70. R.R. Stein, V. Bucci, N.C. Toussaint, C.G. Buffie, G. Rätsch, E.G. Pamer, C. Sander, and J.B. Xavier Ecological modeling from time-series inference: insight into dynamics and stability of intestinal microbiota PLoS Comput. Biol. 9 2013 e1003388
71. J. Tap, S. Mondot, F. Levenez, E. Pelletier, C. Caron, J.P. Furet, E. Ugarte, R. Muñoz-Tamayo, D.L. Paslier, and R. Nalin Towards the human intestinal microbiota phylogenetic core Environ. Microbiol. 11 2009 2574 2584
72. M.H. Tschöp, P. Hugenholtz, and C.L. Karp Getting to the core of the gut microbiome Nat. Biotechnol. 27 2009 344 346
73. P.J. Turnbaugh, R.E. Ley, M.A. Mahowald, V. Magrini, E.R. Mardis, and J.I. Gordon An obesity-associated gut microbiome with increased capacity for energy harvest Nature 444 2006 1027 1031
74. P.J. Turnbaugh, M. Hamady, T. Yatsunenko, B.L. Cantarel, A. Duncan, R.E. Ley, M.L. Sogin, W.J. Jones, B.A. Roe, and J.P. Affourtit A core gut microbiome in obese and lean twins Nature 457 2009 480 484
75. P.J. Turnbaugh, C. Quince, J.J. Faith, A.C. McHardy, T. Yatsunenko, F. Niazi, J. Affourtit, M. Egholm, B. Henrissat, R. Knight, and J.I. Gordon Organismal, genetic, and transcriptional variation in the deeply sequenced gut microbiomes of identical twins Proc. Natl. Acad. Sci. USA 107 2010 7503 7508
76. S. Viaud, F. Saccheri, G. Mignot, T. Yamazaki, R. Daillère, D. Hannani, D.P. Enot, C. Pfirschke, C. Engblom, and M.J. Pittet The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide Science 342 2013 971 976
77. M. Vijay-Kumar, J.D. Aitken, F.A. Carvalho, T.C. Cullender, S. Mwangi, S. Srinivasan, S.V. Sitaraman, R. Knight, R.E. Ley, and A.T. Gewirtz Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5 Science 328 2010 228 231
78. A. Vrieze, C. Out, S. Fuentes, L. Jonker, I. Reuling, R.S. Kootte, E. van Nood, F. Holleman, M. Knaapen, and J.A. Romijn Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity J. Hepatol. 60 2014 824 831
79. A.W. Walker, J. Ince, S.H. Duncan, L.M. Webster, G. Holtrop, X. Ze, D. Brown, M.D. Stares, P. Scott, and A. Bergerat Dominant and diet-responsive groups of bacteria within the human colonic microbiota ISME J. 5 2011 220 230
80. B.D. Wallace, H. Wang, K.T. Lane, J.E. Scott, J. Orans, J.S. Koo, M. Venkatesh, C. Jobin, L.A. Yeh, S. Mani, and M.R. Redinbo Alleviating cancer drug toxicity by inhibiting a bacterial enzyme Science 330 2010 831 835
81. L. Wen, R.E. Ley, P.Y. Volchkov, P.B. Stranges, L. Avanesyan, A.C. Stonebraker, C. Hu, F.S. Wong, G.L. Szot, and J.A. Bluestone Innate immunity and intestinal microbiota in the development of Type 1 diabetes Nature 455 2008 1109 1113
82. A. Wijeyesekera, P.A. Clarke, M. Bictash, I.J. Brown, M. Fidock, T. Ryckmans, I.K. Yap, Q. Chan, J. Stamler, and P. Elliott Quantitative UPLC-MS/MS analysis of the gut microbial co-metabolites phenylacetylglutamine, 4-cresyl sulphate and hippurate in human urine: INTERMAP Study Anal. Methods 4 2012 65 72
83. R.J. Williams Biochemical Individuality: The Basis for the Genetotrophic Concept 1956 Wiley New York
84. G.D. Wright The antibiotic resistome: the nexus of chemical and genetic diversity Nat. Rev. Microbiol. 5 2007 175 186
85. T. Yatsunenko, F.E. Rey, M.J. Manary, I. Trehan, M.G. Dominguez-Bello, M. Contreras, M. Magris, G. Hidalgo, R.N. Baldassano, and A.P. Anokhin Human gut microbiome viewed across age and geography Nature 486 2012 222 227
86. X. Zheng, A. Zhao, G. Xie, Y. Chi, L. Zhao, H. Li, C. Wang, Y. Bao, W. Jia, and M. Luther Melamine-induced renal toxicity is mediated by the gut microbiota Sci. Transl. Med. 5 2013 172ra122
87. E.G. Zoetendal, A.D. Akkermans, and W.M. De Vos Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria Appl. Environ. Microbiol. 64 1998 3854 3859